{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:41:56Z","timestamp":1780728116020,"version":"3.54.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007637","name":"Colombia Ministerio de Ciencia Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jcyt.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:31:22Z","timestamp":1656721882000},"page":"1035-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1\/2 clinical trial"],"prefix":"10.1016","volume":"24","author":[{"given":"Martha L.","family":"Arango-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9856-1484","authenticated-orcid":false,"given":"V\u00edctor Alfonso","family":"Solarte-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4499-5885","authenticated-orcid":false,"given":"Silvia M.","family":"Becerra-Bayona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Callegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia L.","family":"Sossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-3388","authenticated-orcid":false,"given":"Miguel Enrique Ochoa","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia C.","family":"Mateus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-7116","authenticated-orcid":false,"given":"Sergio","family":"Eduardo serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ardila-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-9038","authenticated-orcid":false,"given":"Lady T. Girat\u00e1","family":"Viviescas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jcyt.2022.04.002_bib0001","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00592-021-01742-6","article-title":"Decision models in type 2 diabetes mellitus: A systematic review","volume":"58","author":"Li","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0002","series-title":"Diabetic Foot Ulcer","author":"Oliver","year":"2021"},{"issue":"3","key":"10.1016\/j.jcyt.2022.04.002_bib0003","first-page":"302","article-title":"Evaluation and management of lower-extremity ulcers","volume":"378","author":"Singer","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jcyt.2022.04.002_bib0004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1302\/2058-5241.3.180010","article-title":"Current concepts for the evaluation and management of diabetic foot ulcers","volume":"3","author":"Mavrogenis","year":"2018","journal-title":"EFORT Open Rev"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/nyas.13569","article-title":"Update on management of diabetic foot ulcers","volume":"1411","author":"Everett","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.jcyt.2022.04.002_bib0006","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12325-017-0478-y","article-title":"Chronic wound healing: a review of current management and treatments","volume":"34","author":"Han","year":"2017","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-019-1212-2","article-title":"Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies","volume":"10","author":"Nourian Dehkordi","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcyt.2020.08.012","article-title":"Ex vivo-expanded highly pure ABCB5(+) mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data","volume":"23","author":"Kerstan","year":"2021","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0009","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.burns.2020.04.012","article-title":"Mesenchymal stem cell therapy of acute thermal burns: A systematic review of the effect on inflammation and wound healing","volume":"47","author":"Rangatchew","year":"2021","journal-title":"Burns"},{"issue":"5","key":"10.1016\/j.jcyt.2022.04.002_bib0010","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3390\/ijms22052410","article-title":"Applications of mesenchymal stromal cellss in skin regeneration and rejuvenation","volume":"22","author":"Jo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0011","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13287-021-02697-9","article-title":"The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review","volume":"13","author":"Bian","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12015-020-10014-9","article-title":"Mesenchymal stromal cell-derived extracellular vesicles in the treatment of diabetic foot ulcers: application and challenges","volume":"17","author":"An","year":"2021","journal-title":"Stem Cell Rev Rep"},{"issue":"6","key":"10.1016\/j.jcyt.2022.04.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177533","article-title":"The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice","volume":"12","author":"de Mayo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1461648","article-title":"Regenerative potential of mesenchymal stromal cells: age-related changes","volume":"2016","author":"Bruna","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0015","first-page":"0164","article-title":"Mesenchymal stem cells derivatives as a novel and potential therapeutic approach to treat diabetic foot ulcers","volume":"19","author":"Becerra-Bayona","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2022.04.002_bib0016","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1002\/dmrr.464","article-title":"Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies","volume":"20","author":"Schaper","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5435\/00124635-200702000-00007","article-title":"The 36-item short form","volume":"15","author":"Patel","year":"2007","journal-title":"J Am Acad Orthop Surg"},{"issue":"7","key":"10.1016\/j.jcyt.2022.04.002_bib0018","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/j.pain.0000000000000457","article-title":"Pain assessment in context: a state of the science review of the McGill pain questionnaire 40 years on","volume":"157","author":"Main","year":"2016","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0019","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2106\/JBJS.M.00058","article-title":"Adult human mesenchymal stromal cellss delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study","volume":"96","author":"Vangsness","year":"2014","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.jcyt.2022.04.002_bib0021","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/cns.12759","article-title":"Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy","volume":"23","author":"Dahbour","year":"2017","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0022","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12975-019-00707-w","article-title":"Therapeutic role of a cysteine precursor, OTC, in ischemic stroke is mediated by improved proteostasis in mice","volume":"11","author":"Liu","year":"2020","journal-title":"Transl Stroke Res"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12974-021-02081-7","article-title":"Peripherally misfolded proteins exacerbate ischemic stroke-induced neuroinflammation and brain injury","volume":"18","author":"Liu","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang da","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"issue":"12","key":"10.1016\/j.jcyt.2022.04.002_bib0026","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stromal cellss as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev"},{"issue":"10","key":"10.1016\/j.jcyt.2022.04.002_bib0027","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0028","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5009\/gnl17035","article-title":"Umbilical cord mesenchymal stromal cells treatment for crohn's disease: a randomized controlled clinical trial","volume":"12","author":"Zhang","year":"2018","journal-title":"Gut Liver"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcyt.2018.11.003","article-title":"Safety and efficacy of allogenic placental mesenchymal stromal cellss for treating knee osteoarthritis: a pilot study","volume":"21","author":"Khalifeh Soltani","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0030","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.2147\/DDDT.S225613","article-title":"Efficacy and safety of umbilical cord mesenchymal stromal cells therapy for rheumatoid arthritis patients: a prospective phase I\/II study","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"10.1016\/j.jcyt.2022.04.002_bib0031","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41591-020-1050-x","article-title":"Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study","volume":"26","author":"Bloor","year":"2020","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.jcyt.2022.04.002_bib0032","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1756-185X.13015","article-title":"Effects of allogeneic mesenchymal stromal cells transplantation in the treatment of liver cirrhosis caused by autoimmune diseases","volume":"20","author":"Liang","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.jcyt.2022.04.002_bib0033","doi-asserted-by":"crossref","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","article-title":"Efficacy and safety of intravenous mesenchymal stromal cellss for ischemic stroke","volume":"96","author":"Chung","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jcyt.2022.04.002_bib0034","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1161\/STROKEAHA.119.026318","article-title":"Phase I\/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stromal cellss in chronic stroke","volume":"50","author":"Levy","year":"2019","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jcyt.2022.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/sctm.20-0497","article-title":"Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year","volume":"10","author":"Carstens","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8863649","article-title":"Combined transplantation of mesenchymal stromal cellss and endothelial colony-forming cells accelerates refractory diabetic foot ulcer healing","volume":"2020","author":"Zhao","year":"2020","journal-title":"Stem Cells Int"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0037","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/db18-0699","article-title":"Potential of allogeneic adipose-derived stem cell-hydrogel complex for treating diabetic foot ulcers","volume":"68","author":"Moon","year":"2019","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.jcyt.2022.04.002_bib0038","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fas.2020.08.002","article-title":"Intralesional allogeneic adipose-derived stem cells application in chronic diabetic foot ulcer: Phase I\/2 safety study","volume":"27","author":"Uzun","year":"2020","journal-title":"Foot Ankle Surg"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0039","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13287-020-01695-7","article-title":"Efficacy and safety of umbilical cord mesenchymal stromal cellss in treatment of cesarean section skin scars: a randomized clinical trial","volume":"11","author":"Fan","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2022.04.002_bib0040","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jocd.13063","article-title":"The effect of human umbilical cord blood-derived mesenchymal stromal cells media containing serum on recovery after laser treatment: A double-blinded, randomized, split-face controlled study","volume":"19","author":"Kim","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"8","key":"10.1016\/j.jcyt.2022.04.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020479","article-title":"A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol","volume":"8","author":"van Rhijn-Brouwer","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0042","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/stem.2401","article-title":"Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: Phase I\/IIa studies","volume":"35","author":"Kim","year":"2017","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0043","doi-asserted-by":"crossref","first-page":"e143606","DOI":"10.1172\/jci.insight.143606","article-title":"Intravenous allogeneic umbilical cord blood-derived mesenchymal stromal cells therapy in recessive dystrophic epidermolysis bullosa patients","volume":"6","author":"Lee","year":"2021","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.jcyt.2022.04.002_bib0044","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/09546634.2018.1467541","article-title":"The efficacy of topical human amniotic membrane-mesenchymal stromal cells-conditioned medium (hAMMSC-CM) and a mixture of topical hAMMSC-CM\u00a0+\u00a0vitamin C and hAMMSC-CM\u00a0+\u00a0vitamin E on chronic plantar ulcers in leprosy: A randomized control trial","volume":"29","author":"Prakoeswa","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jcyt.2022.04.002_bib0045","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/0963689719835177","article-title":"Long-term outcomes of BMMSC Compared with BMMNC for treatment of critical limb ischemia and foot ulcer in patients with diabetes","volume":"28","author":"Lu","year":"2019","journal-title":"Cell Transplant"},{"issue":"12","key":"10.1016\/j.jcyt.2022.04.002_bib0046","first-page":"E125","article-title":"Malignant Transformation of a Site of Prior Diabetic Foot Ulceration to Verrucous Carcinoma: A Case Report","volume":"29","author":"Priesand","year":"2017","journal-title":"Wounds"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0047","article-title":"Mistaken diabetic ulcers: A case of bilateral foot verrucous carcinoma","volume":"2018","author":"Di Palma","year":"2018","journal-title":"Case Rep Dermatol Med"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0048","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/geriatrics4040062","article-title":"Malignant transformation in diabetic foot ulcers\u08e7case reports and review of the literature","volume":"4","author":"Dorr","year":"2019","journal-title":"Geriatrics (Basel)"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0049","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/pathogens11020271","article-title":"Methods of inactivation of highly pathogenic viruses for molecular, serology or vaccine development purposes","volume":"11","author":"Elveborg","year":"2022","journal-title":"Pathogens"},{"issue":"10","key":"10.1016\/j.jcyt.2022.04.002_bib0050","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/AEM.00081-11","article-title":"Inactivation of a human norovirus surrogate, human norovirus virus-like particles, and vesicular stomatitis virus by gamma irradiation","volume":"77","author":"Feng","year":"2011","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"10.1016\/j.jcyt.2022.04.002_bib0051","first-page":"432","article-title":"Gamma-irradiation of serum for the inactivation of adventitious contaminants","volume":"64","author":"Gauvin","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"issue":"7","key":"10.1016\/j.jcyt.2022.04.002_bib0052","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/v8070204","article-title":"Inactivation of RNA viruses by gamma irradiation: A study on mitigating factors","volume":"8","author":"Hume","year":"2016","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.jcyt.2022.04.002_bib0053","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/14653249.2011.583232","volume":"13","author":"Chieregato","year":"2011","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0054","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/ten.tec.2010.0406","article-title":"Optimization of culture conditions for the expansion of umbilical cord-derived mesenchymal stem or stromal cell-like cells using xeno-free culture conditions","volume":"17","author":"Hatlapatka","year":"2011","journal-title":"Tissue Eng Part C Methods"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0055","doi-asserted-by":"crossref","first-page":"e10246","DOI":"10.1371\/journal.pone.0010246","article-title":"A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells","volume":"5","author":"Rajala","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jcyt.2022.04.002_bib0056","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.jcyt.2022.04.002_bib0057","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00441-012-1393-9","article-title":"Mechanisms of action of mesenchymal stromal cellss in cutaneous wound repair and regeneration","volume":"348","author":"Li","year":"2012","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0058","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13063-020-04948-1","volume":"22","author":"Gugerell","year":"2021","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.jcyt.2022.04.002_bib0059","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI32169","article-title":"Cellular and molecular basis of wound healing in diabetes","volume":"117","author":"Brem","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0060","doi-asserted-by":"crossref","first-page":"9717","DOI":"10.2147\/IJN.S276001","article-title":"Potential applications of nanomaterials and technology for diabetic wound healing","volume":"15","author":"Bai","year":"2020","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0061","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1524-475X.2009.00466.x","article-title":"Interactions between extracellular matrix and growth factors in wound healing","volume":"17","author":"Schultz","year":"2009","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0062","doi-asserted-by":"crossref","unstructured":"Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic wound-healing science, Medicina (Kaunas) 2021;57(10):1072.","DOI":"10.3390\/medicina57101072"},{"issue":"8","key":"10.1016\/j.jcyt.2022.04.002_bib0063","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1089\/wound.2012.0370","article-title":"Proteases and delayed wound healing","volume":"2","author":"McCarty","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0064","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fbioe.2019.00469","article-title":"Growth factor engineering strategies for regenerative medicine applications","volume":"7","author":"Ren","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jcyt.2022.04.002_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2015.11.007","article-title":"Engineering growth factors for regenerative medicine applications","volume":"30","author":"Mitchell","year":"2016","journal-title":"Acta Biomater"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0066","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13045-021-01037-x","article-title":"Challenges and advances in clinical applications of mesenchymal stromal cells","volume":"14","author":"Zhou","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0067","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12917-018-1527-8","article-title":"Allogeneic mesenchymal stromal cellss improve the wound healing process of sheep skin","volume":"14","author":"Martinello","year":"2018","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.jcyt.2022.04.002_bib0068","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.scr.2011.01.004","article-title":"Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic","volume":"6","author":"Oskowitz","year":"2011","journal-title":"Stem Cell Res"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0069","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/wrr.12398","article-title":"Transforming growth factor beta (TGF-beta) isoforms in wound healing and fibrosis","volume":"24","author":"Lichtman","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/labinvest.2012.162","article-title":"A physiological role for connective tissue growth factor in early wound healing","volume":"93","author":"Alfaro","year":"2013","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0071","doi-asserted-by":"crossref","first-page":"324","DOI":"10.5021\/ad.2021.33.4.324","article-title":"Keratinocyte-like cells trans-differentiated from human adipose-derived stem cells, facilitate skin wound healing in mice","volume":"33","author":"Kim","year":"2021","journal-title":"Ann Dermatol"},{"issue":"8","key":"10.1016\/j.jcyt.2022.04.002_bib0072","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jcyt.2018.06.005","article-title":"Plasminogen activator inhibitor-1 and tenascin-C secreted by equine mesenchymal stromal cells stimulate dermal fibroblast migration in vitro and contribute to wound healing in vivo","volume":"20","author":"Harman","year":"2018","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0073","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/iwj.12551","article-title":"Mesenchymal stem cell-conditioned medium accelerates wound healing with fewer scars","volume":"14","author":"Li","year":"2017","journal-title":"Int Wound J"},{"issue":"4","key":"10.1016\/j.jcyt.2022.04.002_bib0074","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1634\/stemcells.2007-0737","article-title":"The anti-inflammatory and anti-angiogenic role of mesenchymal stromal cellss in corneal wound healing following chemical injury","volume":"26","author":"Oh","year":"2008","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.jcyt.2022.04.002_bib0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jdermsci.2016.03.003","article-title":"Bone marrow derived mesenchymal stromal cellss inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling","volume":"83","author":"Fang","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.jcyt.2022.04.002_bib0076","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s13287-019-1366-y","article-title":"Human amniotic mesenchymal stromal cellss and their paracrine factors promote wound healing by inhibiting heat stress-induced skin cell apoptosis and enhancing their proliferation through activating PI3K\/AKT signaling pathway","volume":"10","author":"Li","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"7-8","key":"10.1016\/j.jcyt.2022.04.002_bib0077","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1002\/jcp.29486","article-title":"Mesenchymal stem cell-conditioned media: A novel alternative of stem cell therapy for quality wound healing","volume":"235","author":"Joseph","year":"2020","journal-title":"J Cell Physiol"},{"issue":"12","key":"10.1016\/j.jcyt.2022.04.002_bib0078","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4252\/wjsc.v12.i12.1529","article-title":"Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine","volume":"12","author":"Gonzalez-Gonzalez","year":"2020","journal-title":"World J Stem Cells"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922006375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922006375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:47:38Z","timestamp":1761443258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922006375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":78,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1465324922006375"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.04.002","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1\/2 clinical trial","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}